Michael Belshan
Overview
Explore the profile of Michael Belshan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deng S, He W, Gong A, Li M, Wang Y, Xia Z, et al.
Nat Commun
. 2023 Mar;
14(1):1456.
PMID: 36928642
Cryptosporidium infects gastrointestinal epithelium and is a leading cause of infectious diarrhea and diarrheal-related death in children worldwide. There are no vaccines and no fully effective therapy available for the...
2.
Mandal S, Sunagawa S, Prathipati P, Belshan M, Shibata A, Destache C
Nanomaterials (Basel)
. 2022 Jun;
12(11).
PMID: 35683795
The C-C motif chemokine receptor-5 (CCR5) expression on the T-cell surface is the prime barrier to HIV/AIDS eradication, as it promotes both active human immunodeficiency virus (HIV)-infection and latency; however,...
3.
Siedlik J, Watson C, Raine M, Cheng A, Goering R, Stessman H, et al.
Front Microbiol
. 2022 Jun;
13:878342.
PMID: 35663859
COVID-19 emerged at varying intervals in different regions of the United States in 2020. This report details the epidemiologic and genetic evolution of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
4.
Macur K, Zieschang S, Lei S, Morsey B, Jaquet S, Belshan M, et al.
Proteomics
. 2021 May;
21(15):e2100005.
PMID: 34051048
HIV-1 infection of macrophages is a multistep and multifactorial process that has been shown to be enhanced by exposure to methamphetamine (Meth). In this study, we sought to identify the...
5.
Belshan M, Holbrook A, George J, Durant H, Callahan 2nd M, Jaquet S, et al.
Virology
. 2021 Mar;
558:86-95.
PMID: 33735754
Infection with HIV-1 remains uncurable due to reservoirs of latently infected cells. Any potential cure for HIV will require a mechanism to identify and target these cells in vivo. We...
6.
Tso F, Lidenge S, Poppe L, Pena P, Privatt S, Bennett S, et al.
PLoS One
. 2021 Mar;
16(3):e0247640.
PMID: 33661923
Background: Neutralizing-antibody (nAb) is the major focus of most ongoing COVID-19 vaccine trials. However, nAb response against SARS-CoV-2, when present, decays rapidly. Given the myriad roles of antibodies in immune...
7.
Holbrook A, Peterson H, Bianchi S, Macdonald B, Bredahl E, Belshan M, et al.
Physiol Rep
. 2019 Sep;
7(18):e14234.
PMID: 31552706
Early studies in exercise immunology suggested acute bouts of exercise had an immunosuppressive effect in human subjects. However, recent data, show acute bouts of combined aerobic and resistance training increase...
8.
Mandal S, Prathipati P, Belshan M, Destache C
Antiviral Res
. 2019 Apr;
167:83-88.
PMID: 30991088
Bictegravir (BIC), a newly FDA-approved integrase strand transfer inhibitor (INSTI), as a single tablet regimen has proven efficacious in treating HIV-1 and SIV viruses, with reduced resistance. BIC clinical trials...
9.
DeBoer J, Wojtkiewicz M, Haverland N, Li Y, Harwood E, Leshen E, et al.
Virology
. 2018 Feb;
516:246-257.
PMID: 29425767
Viral pathogenesis results from changes in host cells due to virus usurpation of the host cell and the innate cellular responses to thwart infection. We measured global changes in protein...
10.
Mandal S, Belshan M, Holec A, Zhou Y, Destache C
Antimicrob Agents Chemother
. 2016 Nov;
61(1).
PMID: 27821449
Among various FDA-approved combination antiretroviral drugs (cARVs), emtricitabine (FTC) has been a very effective nucleoside reverse transcriptase inhibitor. Thus far, FTC is the only deoxycytidine nucleoside analog. However, a major...